Pfenex and Glide Pharma have an ongoing collaboration to develop an anthrax vaccine containing the...
Glide Technologies is a UK development company focused on solid dose formulations of therapeutics and vaccines, and non-invasive diagnostics.
Glide's SDI (solid dose injection) system comprises a re-useable spring powered actuator and a disposable single use cassette, which houses the vaccine formulated in a small solid formulation.
Pressing the loaded Glide SDI against the injection site 'charges' a spring in the actuator, which at a preset compression force pushes the vaccine into the subcutaneous layer.
The formulation dissolves, releasing the API or vaccine antigens into the surrounding tissue.
Download to find out more.
Glide Technologies Announces Successful Proof-of-Concept with Novel Exenatide Solid Dose Formulation
Glide Technologies has announced that they have successfully completed a pre-clinical proof-of-concept study with its...